Skip to main content
. 2018 Mar 6;20(4):351–363. doi: 10.1016/j.neo.2018.01.011

Supplemental Figure S3.

Supplemental Figure S3

(A) IPA of RNA-seq data identified top canonical pathways altered in C4-2 cells treated with siRNA control (siCont) compared to siEAF2 alone. (B) IPA top canonical pathways altered in C4-2 cells treated with siCont compared to sip53. (C) IPA top diseases and cellular functions altered in C4-2 cells treated with siCont compared to siEAF2. (D) IPA top diseases and cellular functions altered in C4-2 cells treated with siCont compared to sip53.